Related Experiment Video
Updated: Aug 19, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
The pathogenesis of infective endocarditis
1Department of Medicine, VA West Los Angeles Medical Center, California 90073.
Insights
Infective endocarditis pathogenesis involves vegetation size and host defenses. Polymorphonuclear leukocytes may limit vegetations but contribute to valve damage, influencing infection outcomes.
Area of Science:
- Cardiovascular Pathology
- Infectious Diseases
- Immunology
Background:
- Infective endocarditis pathogenesis remains incompletely understood.
- Key factors include vegetation characteristics, host immune responses, and experimental infection conditions.
- Subtle or macroscopic vegetations and their clinical implications require further investigation.
Purpose of the Study:
- To review current knowledge on infective endocarditis pathogenesis.
- To explore the roles of vegetation size, host defense mechanisms, and experimental conditions.
- To identify factors influencing the outcome of experimental infective endocarditis.
Main Methods:
- Review of existing literature on experimental infective endocarditis models.
- Analysis of studies involving anticoagulants and their effect on vegetation formation.
- Examination of the role of polymorphonuclear leukocytes in infection development and valve damage.
- Investigation of bacterial inoculum size and catheterization duration in experimental settings.
Main Results:
- Fatal infective endocarditis can occur without macroscopic vegetations in animal models.
- Polymorphonuclear leukocytes may limit vegetations in the vascular system but contribute to left-sided heart infections and valve perforation.
- Bacterial challenge size and catheterization duration significantly impact experimental infection outcomes and antibiotic prophylaxis effectiveness.
Conclusions:
- Detection of non-macroscopic vegetations in humans could alter understanding of endocarditis epidemiology and clinical course.
- Polymorphonuclear leukocytes play a dual role in infective endocarditis, potentially limiting infection while also causing valve damage.
- Standardization of bacterial inoculum and catheterization duration is crucial for comparing prophylactic measures in experimental studies.
Abstract:
Three aspects of our current understanding of the pathogenesis of infective endocarditis are reviewed: the size of the infected vegetation, host defence mechanisms and conditions which determine the outcome of experimental infection. Animal studies have been conducted with anticoagulants in which fatal infective endocarditis was produced without macroscopic evidence of endocardial vegetations. Detection of such lesions in man would change our perception of the epidemiology and clinical course of the disorder. It is probable that polymorphonuclear leucocytes are important in limiting the development of infected vegetations throughout the vascular system and, because of their ineffectiveness in the left side of the heart, are probably responsible for the preponderance of infections within that particular part of the circulation. Furthermore, polymorphonuclear leucocytes may also contribute to the pathogenesis of valve perforation. Finally, the size of the bacterial challenge, and the duration of catheterization of the heart to induce infection, have been shown to significantly influence the natural history of experimental infection and also the effectiveness of prophylactic antibiotics. Any comparison of the effectiveness of different prophylactic measures will require careful standardization of these conditions. It is difficult to determine the optimal size of the bacterial inoculum in animal studies since so little is known about this factor in man. Peripheral infections in animals may disseminate sufficient bacteria to produce endocardial infection and yet not be easily, if at all, detectable in the circulating blood.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction

